ArticlebioRxiv : the preprint server for biology2020
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design.
Wioletta Rut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.